1
|
Havelka EM, Sanfilippo JE, Juneau PL, Sherman G, Cooper D, Leggio L. The effect of alcohol, tobacco, and other drug use on vaccine acceptance, uptake, and adherence: a systematic review. Alcohol Alcohol 2024; 59:agae057. [PMID: 39371015 PMCID: PMC11456869 DOI: 10.1093/alcalc/agae057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2024] [Revised: 08/01/2024] [Accepted: 08/05/2024] [Indexed: 10/08/2024] Open
Abstract
BACKGROUND Vaccine hesitancy is increasingly recognized as a health challenge affecting populations worldwide. Given the biological vulnerabilities and structural barriers people who use substances and/or have behavioral addictions face, this systematic review aims to evaluate whether this subpopulation is less prone to adhere to vaccination recommendations. METHODS Electronic searches of published original research were conducted in PubMed, EMBASE, Scopus, and PsycINFO from database inception to December 2022. Our strategy encompassed retrievals regardless of languages and date of publication. Animal studies, abstracts without a full manuscript, and studies which were considered to have lower robustness of scientific evidence were excluded. Outcomes measured were vaccine acceptance, uptake, and adherence. Results were interpreted through a narrative synthesis. RESULTS The search yielded 103 retrievals encompassing data collected on 5 576 374 persons who were predominantly residents of Europe (n = 39) and North America (n = 27). Tobacco use, the substance for which many studies were found (n = 91), was significantly associated with poorer vaccine acceptance, uptake and adherence for influenza, COVID-19, human papillomavirus (HPV), and maternal and childhood vaccines. Peri-natal and parental substance use was identified as a risk factor for suboptimal vaccine-related outcomes concerning maternal COVID-19 and childhood vaccines. Finally, people identified as 'using', 'abusing', or 'misusing' drugs or substances may be at decreased odds of all outcomes in various vaccines. CONCLUSIONS Collectively, the studies identified several groups with statistically significant greater vaccine hesitancy and decreased engagement among whom targeted measures could be beneficial. Timely evidence, especially on behavioral addictions and substances besides tobacco, is lacking, and warrants urgent attention.
Collapse
Affiliation(s)
- Eva M Havelka
- Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, 251 Bayview Blvd, Suite 200, Baltimore, MD 21224, United States
- Centre for Addictive Disorders, Department of Adult Psychiatry, Psychiatric University Hospital Zurich, University of Zurich, Zurich, 8001, Switzerland
| | - Jenna E Sanfilippo
- Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, 251 Bayview Blvd, Suite 200, Baltimore, MD 21224, United States
- Northwestern University Feinberg School of Medicine Department of Psychiatry & Behavioral Sciences, Chicago, IL 60611, United States
| | - Paul L Juneau
- National Institutes of Health Library, Office of Research Services, National Institutes of Health, Bethesda, MD 20894, United States
| | - Garrick Sherman
- Office of the Clinical Director, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, United States
| | - Diane Cooper
- Office of Research Services, Division of Library Services, National Institutes of Health; Building 10 Bethesda, MD 20892, United States
| | - Lorenzo Leggio
- Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, 251 Bayview Blvd, Suite 200, Baltimore, MD 21224, United States
| |
Collapse
|
2
|
Badlis S, Yu H, Klusaritz H, S L Tan A, Dooley T, Heggs H, Collins S, Raczka G, DeRoche-Brown N, Feuerstein-Simon R, Bauermeister JA, Villarruel AM, Bonett S, Glanz K, Lipman T. Engaging Trusted Messengers to Increase COVID-19 Pediatric Vaccine Uptake in Philadelphia: Lessons from the VaxUpPhillyFamilies program. Vaccine 2024; 42:126040. [PMID: 38853034 DOI: 10.1016/j.vaccine.2024.06.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2024] [Accepted: 06/01/2024] [Indexed: 06/11/2024]
Abstract
INTRODUCTION Communities of color had higher rates of Coronavirus (COVID-19) infection and lower rates of COVID-19 vaccination during the pandemic. Parental concern about the safety and necessity of pediatric COVID-19 vaccines contribute to low childhood vaccination. Enlisting parents and caregivers as trusted messengers is an evidence-based approach to mitigate this challenge. VaxUpPhillyFamilies was formed to engage parents and caregivers as vaccine ambassadors to increase vaccination rates in children of color. This study aimed to understand the key benefits, challenges, and lessons learned from the VaxUpPhillyFamilies program. METHODS Three online debriefing sessions with ambassadors were conducted between September 7 and October 24, 2022, to share best practices, address challenges, receive emerging vaccine information, and provide support. Thematic analysis was utilized to develop broad themes and subthemes. RESULTS Four themes with corresponding subthemes were identified: 1) Motivations to Become an Ambassador: a) improving the health of the community and b) personal satisfaction; 2) Defining Success: a) community interactions and b) influencing opinions; 3) Best Approaches: a) being mentally prepared with facts, b) addressing community health needs beyond COVID-19, c) demonstrating empathy, d) "meeting them where they're at" by motivational interviewing, and e) building trust and connection; 4) Challenges: a) changes in vaccine guidelines, b) vaccine misinformation, c) varied perceptions of severity of COVID-19 illness and benefits of the vaccine, d) breakdown of communication from trusted sources, and e) structural barriers to engagement. CONCLUSION Parents and caregivers were a resource for delivering evidence-based messaging about COVID-19 and other health challenges. To effectively equip parents and caregivers as public health ambassadors, it is critical to offer training in engagement strategies, to identify and combat misinformation, and to provide support in navigating challenges. VaxUpPhillyFamilies program is a model for future public health campaigns.
Collapse
Affiliation(s)
- Sarah Badlis
- University of Pennsylvania School of Nursing, Philadelphia, PA, United States.
| | - Haolong Yu
- University of Pennsylvania Graduate School of Education, Philadelphia, PA, United States
| | - Heather Klusaritz
- University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States
| | - Andy S L Tan
- University of Pennsylvania Annenberg School for Communication, Philadelphia, PA, United States
| | - Teresa Dooley
- University of Pennsylvania, Philadelphia, PA, United States
| | - Helaine Heggs
- University of Pennsylvania, Philadelphia, PA, United States
| | - Sophia Collins
- Children's Hospital of Philadelphia, Philadelphia, PA, United States
| | | | | | | | - José A Bauermeister
- University of Pennsylvania School of Nursing, Philadelphia, PA, United States
| | | | - Stephen Bonett
- University of Pennsylvania School of Nursing, Philadelphia, PA, United States
| | - Karen Glanz
- City of Philadelphia, Philadelphia, PA, United States
| | - Terri Lipman
- University of Pennsylvania School of Nursing, Philadelphia, PA, United States
| |
Collapse
|
3
|
Schelbar N, Ward CN, Phillips E, Herr MJ, Acevedo S, Conner H, Greiner A, Corriveau E. Impact of COVID-19 pandemic and vaccine perceptions on HPV vaccine hesitancy. Am J Otolaryngol 2024; 45:104172. [PMID: 38103489 DOI: 10.1016/j.amjoto.2023.104172] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2023] [Accepted: 12/05/2023] [Indexed: 12/19/2023]
Abstract
OBJECTIVE This study evaluated the impact of the COVID-19 pandemic and vaccine perceptions on Human Papillomavirus (HPV) vaccine hesitancy. Secondary endpoints included comparing COVID-19 and HPV vaccination trends regarding time, community of residence, and unmet social needs. METHODS This was a survey-based, cross-sectional study that included 101 participants who were recruited through the Wyandotte County Public Health Department. Participants were eligible for inclusion in this study if they were a parent/guardian of one or more children aged 13 to 17; English- or Spanish-speaking. This study took place in Wyandotte County, Kansas. Descriptive statistics and chi-square analyses were utilized. RESULTS There was no difference in completion of COVID-19 and HPV vaccines (p = 0.0975). Significantly more individuals started and did not finish the HPV vaccine series compared to the COVID-19 vaccine series (p = 0.0004). Most participants indicated their opinion on the HPV vaccine had not changed due to the pandemic (71.3 %). Participants who felt familiar with HPV had higher rates of HPV vaccine completion. While 77 % of participants felt extremely or moderately familiar with HPV, 61.4 % were unaware of its association with oropharyngeal cancer. CONCLUSION There was minimal change in parents' perception of the HPV vaccine due to the COVID-19 pandemic despite decreased rates of vaccination during this time. HPV vaccine series completion was significantly lower than COVID-19 vaccine series completion, highlighting a need to improve HPV vaccine completion counseling. Additionally, patient education should address the knowledge gap discovered regarding the link between HPV infection and oropharyngeal cancer.
Collapse
Affiliation(s)
- Natalie Schelbar
- University of Kansas School of Medicine, Kansas City, KS, United States of America.
| | - Christina N Ward
- University of Tennessee Health Science Center, Department of Otolaryngology-Head & Neck Surgery, Memphis, TN, United States of America
| | - Elaine Phillips
- University of Kansas School of Medicine, Kansas City, KS, United States of America
| | - Michael J Herr
- University of Alabama at Birmingham Heersink School of Medicine, Department of Cell, Developmental, and Integrative Biology, United States of America
| | - Sarah Acevedo
- University of Virginia, Department of Medicine, Charlottesville, VA, United States of America
| | - Hannah Conner
- Wyandotte County Unified Government Public Health Department, Kansas City, KS, United States of America
| | - Allen Greiner
- Wyandotte County Unified Government Public Health Department, Kansas City, KS, United States of America; University of Kansas Medical Center Department of Family Medicine & Community Health, Kansas City, KS, United States of America
| | - Erin Corriveau
- Wyandotte County Unified Government Public Health Department, Kansas City, KS, United States of America; University of Kansas Medical Center Department of Family Medicine & Community Health, Kansas City, KS, United States of America
| |
Collapse
|
4
|
Wang J, Redelmeier DA. Vaccine Hesitancy and Traffic Deaths: Ecological Analyses. J Gen Intern Med 2023; 38:1783-1785. [PMID: 36690912 PMCID: PMC9870189 DOI: 10.1007/s11606-022-08008-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Accepted: 12/23/2022] [Indexed: 01/25/2023]
Affiliation(s)
- Jonathan Wang
- Evaluative Clinical Sciences Program, Sunnybrook Research Institute, Toronto, Canada.,Institute for Clinical Evaluative Sciences, Toronto, Canada
| | - Donald A Redelmeier
- Evaluative Clinical Sciences Program, Sunnybrook Research Institute, Toronto, Canada. .,Institute for Clinical Evaluative Sciences, Toronto, Canada. .,Department of Medicine, University of Toronto, Toronto, Canada. .,Division of General Internal Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. .,Center for Leading Injury Prevention Practice Education & Research, Toronto, Canada.
| |
Collapse
|